It is being studied in diabetic neuropathy (NERVARA Phase 2 trial), sarcoidosis, and ischemic injury models
The benzyl alcohol component inhibits microbial growth, allowing for multiple withdrawals under controlled laboratory handling conditions
The peptide dissolves, the syringe draws cleanly, the injection proceeds without incident
While formal drug interaction studies are limited, AOD-9604 can often be safely combined with other therapies under proper medical supervision
The breadth of BPC-157s preclinical profile spanning gastrointestinal protection, musculoskeletal repair, angiogenesis, neuroprotection, and cytoprotection has sustained interest from research groups investigating tissue repair mechanisms and regenerative biology